Turning Point Brands Reports 23% Revenue Jump on Modern Oral Strength

Turning Point Brands' stock went into a slide this week, losing 33% of its value after the company's fourth-quarter earnings missed analyst expectations and management offered a weak outlook for 2026. The sharp decline came even as the company recorded a 23% jump in overall revenue for Q2 2026, a gain driven by its modern oral business, which sells nicotine pouches. Shares are still up about 50% year over year, underscoring how much confidence investors had built in the pouch segment. The volatility reflects a tension between fast-growing sales and deliberately lower short-term profits.

The modern oral segment generated $41.3 million in revenue last quarter, up 266% from the same period a year earlier, and it now accounts for 34% of Turning Point Brands' total sales. The company's best-known legacy products include Zig-Zag rolling papers and Stoker's chewing tobacco, but the pouch business has become the fastest-growing part of the portfolio. That shift is reshaping the company's revenue mix, with modern oral taking on a central role in its growth strategy. The numbers make clear that pouches, not rolling papers, are where the company is staking its future.

Management expects modern oral net revenue to reach $180 million to $190 million in 2026, which would represent another year of strong expansion. Getting there will require heavy spending on marketing and distribution, and the company has already cautioned that profitability will suffer in the near term. Adjusted earnings for the first quarter are forecast at $24 million to $27 million, a notable drop from the $119 million annualized figure for 2025. These numbers show a trade-off: Turning Point Brands is deliberately sacrificing some current profit to build a larger, more durable pouch business.

After the selloff, Turning Point Brands has a market capitalization of $1.75 billion and trades at a price-to-earnings ratio of 29. That earnings multiple looks steep when profits are falling, but the price-to-sales ratio of 3.7 offers a different perspective. For a company growing revenue at triple-digit rates in its key segment, a sales multiple in that range is not unusually high. Investors are effectively betting that the current investment phase will lead to substantial profits once the pouch brand reaches a larger scale. The stock's decline this week, while sharp, has been seen by some as a potential entry point, though the company remains in a heavy investment phase.

For nicotine pouch buyers across Canada and the United States, this investment push is likely to mean greater availability of Turning Point Brands products and more marketing activity around them. The company's revenue guidance for 2026 points to a large, expanding market for modern oral products. As established players commit more resources to pouches, consumers benefit from more choice and stronger competition. Turning Point Brands' latest results and outlook reinforce the view that nicotine pouches have moved from the periphery to the center of the company's strategy, and by extension, the broader market.